Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs linked to growth hormones may increase the chance of hair loss in women.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Nanostructured lipid carriers can effectively deliver spironolactone to hair follicles for treating hair loss.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

GTL1 is needed to control root hair growth and prevent problems when there are too many nutrients.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Nilotinib can cause keratosis pilaris, a skin condition.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

EGFR inhibitors for lung cancer can cause severe skin issues.

Potassium channel openers like minoxidil boost hair growth.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

The method effectively measures drug impact on DHT levels in prostate treatments.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Latanoprost eye drops may cause skin depigmentation.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.